Barbara K Burton

  • 6680 Citations
1973 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

I am primarily interested in the diagnosis and treatment of patients with inherited metabolic disorders and in clinical trials of new therapies for rare disorders. I have particular interest and expertise in disorders diagnosed through newborn screening (phenylketonuria and others) and in lysosomal storage disorders.

Certifications and Licenses

Clinical Biochemical Genetics
Clinical Genetics (MD)

Training Experience

1975Residency, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)
1977Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital)

Education/Academic qualification

MD, Northwestern University, Feinberg School of Medicine

… → 1973

Research interests

  • Genetic Testing/Counseling
  • Genetics: Medical
  • Metabolism
  • Neurogenetics

Fingerprint Dive into the research topics where Barbara K Burton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Characterization of disease-specific chondroitin sulfate nonreducing end accumulation in mucopolysaccharidosis IVA

Lawrence, R., Prill, H., Vachali, P. P., Adintori, E. G., de Hart, G., Wang, R. Y., Burton, B. K., Pasquali, M. & Crawford, B. E., Jul 20 2020, In : Glycobiology. 30, 7, p. 433-445 13 p.

Research output: Contribution to journalArticle

  • Newborn screening for pompe disease in Illinois: Experience with 684,290 infants

    Burton, B. K., Charrow, J., Hoganson, G. E., Fleischer, J., Grange, D. K., Braddock, S. R., Hitchins, L., Hickey, R., Christensen, K. M., Groepper, D., Shryock, H., Smith, P., Shao, R. & Basheeruddin, K., 2020, In : International Journal of Neonatal Screening. 6, 1, ijns6010004.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up

    on behalf of the PAL-002 and PAL-004 Investigators, 2020, (Accepted/In press) In : Molecular Genetics and Metabolism.

    Research output: Contribution to journalArticle

    Open Access
  • Correction: TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants (Genetics in Medicine, (2019), 21, 3, (601-607), 10.1038/s41436-018-0137-y)

    Dines, J. N., Golden-Grant, K., LaCroix, A., Muir, A. M., Cintrón, D. L., McWalter, K., Cho, M. T., Sun, A., Merritt, J. L., Thies, J., Niyazov, D., Burton, B., Kim, K., Fleming, L., Westman, R., Karachunski, P., Dalton, J., Basinger, A., Ficicioglu, C., Helbig, I. & 12 others, Pendziwiat, M., Muhle, H., Helbig, K. L., Caliebe, A., Santer, R., Becker, K., Suchy, S., Douglas, G., Millan, F., Begtrup, A., Monaghan, K. G. & Mefford, H. C., Aug 1 2019, In : Genetics in Medicine. 21, 8, 1 p.

    Research output: Contribution to journalComment/debate

  • Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria

    Longo, N., Dimmock, D., Levy, H., Viau, K., Bausell, H., Bilder, D. A., Burton, B., Gross, C., Northrup, H., Rohr, F., Sacharow, S., Sanchez-Valle, A., Stuy, M., Thomas, J., Vockley, J., Zori, R. & Harding, C. O., Aug 1 2019, In : Genetics in Medicine. 21, 8, p. 1851-1867 17 p.

    Research output: Contribution to journalArticle

  • 11 Scopus citations